WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018102006) COMPOUNDS FOR THE INHIBITION OF INDOLEAMINE-2,3-DIOXYGENASE ACTIVITY AND USE THEREOF
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/102006    International Application No.:    PCT/US2017/051837
Publication Date: 07.06.2018 International Filing Date: 15.09.2017
IPC:
C07D 207/04 (2006.01), A61K 31/407 (2006.01), A61K 31/424 (2006.01), A61P 35/00 (2006.01), C07D 207/16 (2006.01), C07D 413/12 (2006.01), C07D 409/12 (2006.01), C07D 403/12 (2006.01), C07D 403/06 (2006.01), C07D 413/14 (2006.01), C07D 401/14 (2006.01)
Applicants: ENSEMBLE THERAPEUTICS CORPORATION [US/US]; 99 Erie Street Cambridge, MA 02139-4535 (US)
Inventors: BRIGGS, Timothy, F.; (US).
CIPRIANI, Tyler, J.; (US).
DAVIS, Heather; (US).
DUVALL, Jeremy, R.; (US).
HALE, Stephen, P.; (US).
JIANG, Jun; (US).
LEE, Maurice, D.; (US).
MUNCIPINTO, Giovanni; (US).
OALMANN, Christopher, J.; (US).
SNEDEKER, Cheri; (US)
Agent: BRODOWSKI, Michael, H.; (US).
ASHRAF, Shovon; (US).
BUCHMAN, Joshua, J.; (US).
DAVENPORT, Andrew, M.; (US).
ARGENTIERI, Steven, R.; (US)
Priority Data:
62/428,048 30.11.2016 US
Title (EN) COMPOUNDS FOR THE INHIBITION OF INDOLEAMINE-2,3-DIOXYGENASE ACTIVITY AND USE THEREOF
(FR) COMPOSÉS POUR L'INHIBITION DE L'ACTIVITÉ DE L'INDOLÉAMINE 2,3-DIOXYGÉNASE ET LEUR UTILISATION
Abstract: front page image
(EN)The present invention relates to compounds, and pharmaceutically acceptable compositions thereof, useful as antagonists of indoleamine-2,3-dioxygenase (IDO) activity, and methods of treating IDO-related disorders.
(FR)La présente invention concerne des composés et des compositions pharmaceutiquement acceptables de ceux-ci, utiles en tant qu'antagonistes de l'activité de l'indoléamine 2,3-dioxygénase (IDO), ainsi que des méthodes de traitement de troubles associés à l'IDO.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)